• Home
  • Back to the Future - Bringing Psychodynamic Psychotherapy Back into the Forefront of Substance Dependence Treatment

Back to the Future - Bringing Psychodynamic Psychotherapy Back into the Forefront of Substance Dependence Treatment

  • Saturday, October 17, 2020
  • 9:00 AM - 4:00 PM
  • Zoom


Registration is closed

Sponsored by the faculty of the Intensive Short Term Dynamic Psychotherapy program

CE/CME continuing education - 5.5 credit hours


Between 40-60% of patients with substance abuse drop out of rehabilitation facilities before the end of treatment. Up to 85% of individuals relapse within one year of treatment for substance abuse. In 2017, 70,237 people died from a drug overdose. Although substance abuse has often been viewed from a purely biological point of view, recent research has shown that psychotherapy can greatly enhance the outcomes for these patients. Dr. Lamb will present a unique model of addiction treatment that integrates medication management with psychotherapy, creating outcomes three times the national average. Anyone who has a patient suffering from substance abuse will find her presentation useful.

Video recordings of individual and group psychotherapy sessions will show how to assess the patient’s will to recover from addiction and how to identify and regulate anxiety in people suffering from substance abuse. Dr. Lamb will show videos to illustrate how to incorporate psychodynamic group work into addiction treatment. And, from her role as a psychiatrist, she will describe how to integrate medication management with psychodynamic assessment. She does not treat “addicts”; she treats people who suffer from addiction.

This course will help you learn how to conceptualize substance abuse from a psychodynamic point of view in order to treat it more effectively. And this course will teach you the most important initial skills to prevent dropout in the early stages of treatment whether in a facility or a private practice.


Dr. Kristy Lamb is a medical doctor dual board certified in family medicine and psychiatry. She is the co-founder and CEO of BOLD Health, a medical clinic in Encinitas, California, specializing in ISTDP informed treatment. Her clinic provides medication management, individual and group psychotherapy, intensive outpatient programming, and partial hospitalization programs for people suffering from addiction and mental health disorders.  

Participant Confidentiality and Disclosure Acknowledgement

On behalf of the Washington School of Psychiatry, we are pleased to offer you the opportunity to attend this training in Short-Term Dynamic Psychotherapy.

Your registration acknowledges your understanding that the information and patient disclosures presented during this training are of a highly sensitive nature and are presented for educational purposes. The audio-visual portion of this training is provided by patients who volunteered the use of their treatment sessions for purposes of teaching others these techniques. Their willingness is based on the assurance of complete confidentiality of their identities and histories. You are entrusted with the confidentiality of their identities and histories and the material you will see and hear in this seminar.

In consideration of your registration as a participant in this seminar:

1. The undersigned agrees that no copies will be made or retained of any course materials and patient information regardless of its form.

2. I acknowledge that all videotaped material to which I am permitted access during this seminar is the sole and exclusive property of the presenters. In consideration of my admittance to this seminar, I hereby agree that I shall not electronically or in any other way (eg. transcription) copy or duplicate such material. I further agree that I shall not refer to any specific patient seen, heard or described in such material otherwise. This information shall not be disclosed to anyone regardless of their affiliation to you or the Washington School of Psychiatry including but not limited to employees, legal representative or consultants unless they agree to execute and be bound by the terms of this agreement.

3. I acknowledge that violation on my part of this agreement could cause irreparable injury to The undersigned acknowledge that the unauthorized disclosure of the confidential information whether orally or in writing either in whole or in part, could cause irreparable harm to the Patients; the Presenter; Washington School of Psychiatry, its agents or assigns; Faculty, Clinicians, and Instructors.

4. I therefore agree that in the event of such violation, the presenter shall have the absolute right to obtain from any regulatory body or court having jurisdiction appropriate decrees enjoining any further violation of this agreement.

5. Any posting, reproductions, publishing, distribution, display, and or transmission course materials would constitute an unauthorized disclosure.

6. You hereby agree to indemnify, defend and hold harmless the Washington School of Psychiatry from and against any and all liability and costs incurred by the Washington School of Psychiatry in connection with any claim arising out of any breach or alleged breach of any of your obligations set forth herein. You shall cooperate as fully as reasonably required in the defense of any claim. The Washington School of Psychiatry reserves the right, at its own expense, to assume the exclusive defense and control of any matter otherwise subject to indemnification by you and you shall not in any event settle any matter without the written consent of The Washington School of Psychiatry.

6. Furthermore, if the patient is known to me in any way, personally or professionally, I will immediately excuse myself from the training.

Learning Objectives

Participants will be able to:

  1. Explain a psychodynamic understanding of addiction using the triangle of conflict
  2. Describe what medication assisted treatment is and why it is used in addiction treatment
  3. List three goals of early treatment in addiction
  4. Demonstrate how to integrate MAT into a psychodynamic oriented curriculum in an outpatient setting using psychodynamic markers

The Use of a Structured Intake Commitment Interview to Decrease Drop Out Rates

  1. Identify the 3 most pressing goals in early substance use treatment
  2. Explain what a commitment interview, for engagement in treatment, is and why it is useful
  3. Predict positive and negative prognostic indicators for outcome based on the use of a commitment interview

The Use of Active Defense Identification to Deactivate Projection of Will Upon Entering Treatment

  1. Explain the defense of “projection of will” and why this is the first task in the psychodynamic treatment of addiction
  2. Differentiate between conscious and unconscious therapeutic alliance

The Use of Group Therapy to Treat Substance Dependence

  1. Predict the most common pitfalls in the use of structured group therapy
  2. Understand how to use psychodiagnosis and anxiety discharge pathways to target anxiety regulation
  3. Identify 3 ways to deactivate the projection of will


Participants should claim only the credit commensurate with the extent of their participation in the activity.

The Washington School of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Washington School of Psychiatry maintains responsibility for this program and its contents.

The Washington School of Psychiatry is authorized by the Board of Social Work Examiners in Maryland to sponsor social work continuing education learning activities and maintains full responsibility for this program. This training qualifies for Category I continuing education units.

The Washington School of Psychiatry has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 6388. Programs that do not qualify for NBCC credit are clearly identified. The Washington School of Psychiatry is solely responsible for all aspects of the program.

The Washington School of Psychiatry is accredited by MedChi, The Maryland State Medical Society to provide continuing medical education for physicians.

The School designates the program for a maximum of 5.5 AMA PRA Category I Credit(s)â„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Commercial Support and the Unlabeled use of a commercial product. No member of the planning committee and no member of the faculty for this event have a financial interest or other relationship with any commercial product.

The Washington School of Psychiatry is an independent non-profit organization. It is not affiliated with the government of the District of Columbia or the government of the United States.

The Washington School of Psychiatry is approved to operate by the Higher Education Licensure Commission of the District of Columbia.

The Washington School of Psychiatry

5028 Wisconsin Avenue, Suite 400, Washington, DC 20016-4118

Call us at 202-237-2700 or 202-537-6050

Celebrating its 84th year, the School is an accredited provider of post-graduate continuing education.

The Washington School of Psychiatry is an independent non-profit organization. It is not affiliated with the government of the District of Columbia or the government of the United States.

Copyright © 2020 The Washington School of Psychiatry - All Rights Reserved

Powered by Wild Apricot Membership Software